Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
2 results loaded, newest first. End of these results.
Vaxcyte Inc. announced the commencement of proposed offerings of common stock, pre-funded warrants, and convertible senior notes, aiming to raise funds for clinical development of its Vax-31 programs, manufacturing scale-up, and potential PCV program launches.
Vaxcyte, Inc. has commenced underwritten public offerings of $500 million of its common stock and pre-funded warrants, and $500 million aggregate principal amount of convertible senior notes.